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MaOBJECTIVES This study sought to examine operator experience measured by time-related variables on outcomes
with protected carotid artery stenting (CAS).
BACKGROUND Studies on experience have focused on operator and institutional CAS volumes alone in the absence
of a better metric.
METHODS Using the CHOICE (Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes Through the
Collection of Clinical Evidence) multicenter prospective data from October 1, 2006 to June 1, 2012, 5,841 evaluable
subjects were identiﬁed. Operator experience within this study was assessed using 5 variables for each operator: 1)
baseline CAS volume; 2) time from ﬁrst CAS to each subsequent CAS; 3) time between each CAS; 4) CAS volume in the
institution; and 5) medical specialty (cardiology, surgery, or radiology/neurology). Institutional experience was deter-
mined by CAS volume within the study. Embolic protection device dwell time was used to assess technical performance,
and 30-day death, stroke, or myocardial infarction composed the clinical outcome. Hierarchical logistic regression and
linear mixed models were used.
RESULTS Cardiologists (p < 0.001) along with operators with longer time interval from ﬁrst CAS (p < 0.001) had
reduced embolic protection device dwell times (technical performance). Increased time interval between CAS was the
only independent predictor of 30-day death, stroke, or myocardial infarction (adjusted odds ratio: 1.05, 95% conﬁdence
interval: 1.02 to 1.09, p ¼ 0.005). Prolonged embolic protection device dwell time was associated with 30-day death,
stroke, or myocardial infarction (adjusted odds ratio: 1.08; 95% conﬁdence interval: 1.01 to 1.17; p ¼ 0.03).
CONCLUSIONS The time interval between CAS procedures, specialty assignment, and time from ﬁrst CAS are important
measures of operator experience that may signiﬁcantly affect technical performance and clinical outcome. (J Am Coll
Cardiol Intv 2014;7:1307–17) © 2014 by the American College of Cardiology Foundation.P revious surveys have demonstrated a closeassociation between carotid artery stenting(CAS) experience as represented by operator
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ABBR EV I A T I ON S
AND ACRONYMS
CAS = carotid artery stenting
DS = death and stroke
DSMI = death, stroke, or
myocardial infarction
EPD = embolic protection
device
MI = myocardial infarction
NIHSS = National Institutes of
Health Stroke Scale
Shishehbor et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 7 , N O . 1 1 , 2 0 1 4
Experience and CAS Outcomes N O V E M B E R 2 0 1 4 : 1 3 0 7 – 1 7
1308documents recommend a minimum number
of CAS procedures to achieve competence,
and this has also been a requirement for ran-
domized trials (4–6). However, this simplistic
and broad approach may be inadequate (7–9).SEE PAGE 1318In an attempt to improve our under-
standing of operator-related factors on
technical performance for CAS, we hypoth-
esized that the embolic protection device
(EPD) dwell time previously shown to bepredictive of periprocedural stroke risk (10,11) may
potentially serve as an acceptable metric. We
expanded on the previous measures of experience
(operator and institutional volume) by including
time-dependent variables such as time elapsed
since ﬁrst procedure (as a representation of dura-
tion of time the operator has been practicing CAS)
and time interval between procedures within the
study. Additionally, real-time CAS volume for each
operator was considered. The aim of this analysis
accordingly was to test the effect of several oper-
ator and institution experience characteristics on
EPD dwell time (technical performance) and 30-day
death, stroke, or myocardial infarction (DSMI; clin-
ical outcome) using the large prospective Acculink/
Accunet subgroup of the CHOICE (Carotid Stenting
for High Surgical-Risk Patients; Evaluating Out-
comes Through the Collection of Clinical Evidence)
clinical study.
METHODS
STUDY DESIGN AND PATIENT SELECTION. CHOICE
was a prospective, single-arm, adjudicated, multi-
center, post-market study designed to examine out-
comes of CAS using Abbott Vascular (Santa Clara,
California) carotid stents (Acculink and Xact) and
embolic protection systems (Accunet, Emboshield,
EmboshieldNav6). The studywas initiated in 2006 and
completed in 2012 at 366 sites in the United States and
included 17,925 evaluable patients (96% of the total
enrolled population) treated by 913 operators. Evalu-
able subjects were deﬁned as patients who completed
their 30-day follow-up visit or experienced DSMI
within 30 days following the procedure. The current
analysis pertains to the subgroup of all evaluable pa-
tients (N ¼ 5,841) from the CHOICE clinical data who
were exclusively treated with the Acculink carotid
stent in conjunction with the Accunet distal EPD and
for whom the EPD dwell time was available. Because
operator learning curve and post-procedural outcomes
may vary across devices, this analysis focused on asingle stent, Acculink, and a single EPD, Accunet,
which have the longest history in the CAS practice in
the United States.
To be enrolled, a patient had to be considered to
beneﬁt from carotid revascularization but be at high
surgical risk for carotid endarterectomy and be able to
provide an informed consent for CAS. Carotid disease
requiring treatment was deﬁned as an ultrasound or
angiographic stenosis of the common or internal ca-
rotid artery of $50% for symptomatic or $80% for
asymptomatic patients. Symptomatic status was
determined based on ipsilateral transient ischemic
attack (including amaurosis fugax) or stroke within
180 days before the study procedure. There were no
exclusion criteria for this study. The operators rep-
resented a broad range of medical specialties grouped
under 3 main categories: cardiology, surgery, and
radiology/neurology. The CHOICE study mandated
institutional review board approval and oversight,
adjudication of neurological events, and annual
reporting of study progress to the Food and Drug
Administration.
PATIENT CHARACTERISTICS. Patient demographics,
comorbidities, previous treatment for carotid steno-
sis, aortic arch type, presence of aortic arch disease,
target lesion characteristics, and procedural data were
obtained prospectively and recorded using electronic
case report forms. The baseline characteristics are
summarized in Tables 1 and 2. The patients (N ¼ 5,841)
were treated with Acculink/Accunet by 597 operators
at 248 institutions. Overall, 14% of patients were
symptomatic at the time of CAS, and 22% were octo-
genarians (Table 1). Patient characteristics differed
across the 3 clinician medical specialties (Table 1).
Cardiologists had a higher proportion of patients
with concomitant coronary artery disease (71%) and
congestive heart failure (26%). Alternatively, sur-
geons and radiologists/neurologists had more pa-
tients with previous interventions (42%) or carotid
endarterectomy (40%) to the target lesion and symp-
tomatic carotid disease (28%), respectively (Table 1).
No clinically meaningful differences in vessel char-
acteristics were noted among the 3 groups (Table 2).
OPERATOR AND INSTITUTION EXPERIENCE
CHARACTERISTICS. Operator experience character-
istics were assessed using 5 variables for each oper-
ator within this analysis: 1) baseline operator CAS
volume (self-reported total number of CAS pro-
cedures performed as primary operator before the
operator enrolled his or her ﬁrst patient in CHOICE);
2) time from ﬁrst CAS to each subsequent CAS pro-
cedure for each operator; 3) time between each CAS
procedure for the same operator; 4) operator volume
TABLE 1 Baseline Demographics by Physician Specialty for the Analysis Population (N ¼ 5,841)
Total
(N ¼ 5,841)
Cardiology
(n ¼ 3,969)
Surgery
(n ¼ 1,331)
Radiology/Neurology
(n ¼ 541) p Value
Age, yrs 72  10 (5,840) 72  10 (3,968) 70  10 (1,331) 73  9 (541) <0.001
Age $80 yrs 22 (1306/5,840) 24 (953/3,968) 17 (223/1,331) 24 (130/541) <0.001
Male 62 (3,632/5,841) 63 (2,495/3,969) 60 (794/1,331) 63 (343/541) 0.09
Symptomatic carotid disease 14 (755/5613) 11 (401/3824) 16 (207/1265) 28% (147/524) <0.001
Diabetes mellitus 37 (2,180/5,828) 37 (1,481/3,960) 38 (497/1,327) 37 (202/541) 0.99
Hypertension 90 (5,239/5,818) 91 (3,608/3,954) 87.1 (1,154/1,325) 88.5 (477/539) <0.001
Hypercholesterolemia 87 (5,034/5,760) 89 (3,486/3,924) 84 (1,096/1,304) 85 (452/532) <0.001
Hypercholesterolemia requiring medication 76 (4,362/5,760) 78 (3,054/3,924) 72 (934/1,304) 70 (374/532) <0.001
Current tobacco user 24 (1,328/5,650) 23 (864/3,818) 26 (333/1,304) 25 (131/528) 0.08
History of congestive heart failure 22 (1,289/5,779) 26 (1,006/3,934) 16 (205/1,309) 15 (78/536) <0.001
Previous MI 26 (1,458/5,666) 25 (977/3,848) 27 (351/1,293) 25 (130/525) 0.39
Recent MI within 30 days 1 (66/5,666) 1 (52/3,848) 0.9 (12/1,293) 0.4 (2/525) 0.10
Awaiting cardiac surgery within 30 days 3 (143/5,754) 3 (111/3,911) 2 (26/1,305) 1 (6/538) 0.02
Cardiac arrhythmia 20 (1,160/5,804) 21 (819/3,946) 17 (225/1,322) 22 (116/536) 0.008
Coronary artery disease 67 (3,808/5,694) 71 (2,768/3,888) 59 (755/1,285) 55 (285/521) <0.001
Unstable angina 5 (249/5,351) 5 (194/3,669) 3 (36/1,204) 4 (19/478) 0.004
Chronic obstructive pulmonary disease 23 (1,310/5,713) 23 (911/3,901) 22 (282/1,294) 23 (117/518) 0.50
Chronic kidney disease 18 (1,063/5,800) 19 (736/3,944) 17 (230/1,320) 18 (97/536) 0.60
Unfavorable anatomic conditions for CEA 22 (1,273/5,715) 16 (634/3,899) 37 (475/1,292) 31 (164/524) <0.001
Contralateral occlusion of ICA 15 (834/5,753) 14 (543/3,906) 16 (206/1,307) 16 (85/540) 0.18
Peripheral vascular disease 45 (2,538/5,615) 46 (1,761/3,823) 46 (587/1,272) 37 (190/520) <0.001
Previous interventions to the target lesion 21 (1,240/5,834) 14 (545/3,964) 42 (554/1,330) 26 (141/540) <0.001
Previous CEA to the target lesion 20 (1,149/5,834) 12 (493/3,964) 40 (525/1,330) 24 (131/540) <0.001
Previous PTA to the target lesion 0.5 (31/5,834) 0.5 (18/3,964) 0.8 (11/1,330) 0.4 (2/540) 0.23
Previous stenting to the target lesion 2 (131/5,834) 2 (62/3,964) 4 (56/1,330) 2 (13/540) <0.001
Values are mean  SD (n) or % (n/N).
CEA ¼ carotid endarterectomy; ICA ¼ internal carotid artery; MI ¼ myocardial infarction; PTA ¼ percutaneous transluminal angioplasty.
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1309(number of CAS procedures for each operator within
the study); and 5) operator medical specialty. For
each operator, the time from ﬁrst CAS to each sub-
sequent CAS procedure was calculated by sorting the
procedure dates for each operator within the analysis.
Similarly, the time between each CAS procedure
within the analysis was calculated as the time elapsed
since the previous procedure for the same operator.
Institution experience characteristic was assessed
using 1 variable – total CAS volume for each institu-
tion within the study (institution volume).
Per Table 1, cardiologists performed the majority
of procedures (68%), followed by surgeons (23%)
and radiologists/neurologists (9%). There was a wide
variation in operator and institutional experience
variables as shown in Table 3.
TECHNICAL PERFORMANCE AND CLINICAL OUTCOME.
The EPD dwell time, deﬁned as the time between
EPD deployment and recovery, was used to measure
technical performance. Clinical outcome was
assessed using a composite of post-procedure 30-day
DSMI. In addition, 30-day death and stroke (DS) was
used as an outcome for the adjusted analysis. Allstrokes and suspected strokes were adjudicated by an
independent Clinical Events Adjudication Committee
(Harvard Clinical Research Institute, Boston, Massa-
chusetts) or a sponsor-internal adjudication commit-
tee. As per protocol, patients were assessed by a
NIHSS (National Institutes of Health Stroke Scale)
certiﬁed medical professional (nonoperator) or by
an independent neurologist (i.e., nonoperator) at 3
pre-speciﬁed intervals: 1) within 14 days before CAS;
2) within 24 h post-procedure; and 3) at 30 days.
Stroke was classiﬁed as major if the follow-up NIHSS
assessment was >4 points from the pre-procedure
score. In the absence of a 30-day NIHSS, a stroke
was adjudicated as major if signiﬁcant symptoms
persisted beyond discharge. All other strokes were
categorized as minor. Death and MI were site re-
ported if they occurred anytime through the 30-day
follow-up assessment. The protocol deﬁnition of MI
was based on the development of new pathological
Q waves in $2 leads (Q-wave MI) or elevation of cre-
atine kinase levels to >3 the upper limit of normal
accompanied by elevated creatine kinase-myocardial
band level greater than the upper limit of normal
(non–Q-wave MI). The protocol did not require
TABLE 2 Vessel Characteristics for the Analysis Population (N ¼ 5,895)
Total
(N ¼ 5,895)
Cardiology
(n ¼ 4,006)
Vascular Surgery
(n ¼ 1,344)
Radiology/Neurology
(n ¼ 545) p Value
Lesion location
Left ICA 45 (2,652/5,895) 46 (1,856/4,006) 42 (564/1,344) 43 (232/545) 0.01
Right ICA 45 (2,647/5,895) 46 (1,824/4,006) 43 (583/1,344) 44 (240/545) 0.36
Left CCA 4 (215/5,895) 3 (115/4,006) 6 (83/1,344) 3 (17/545) <0.001
Right CCA 3 (173/5,895) 2 (92/4,006) 4 (59/1,344) 4 (22/545) <0.001
Left ICA/left CCA bifurcation 2 (106/5,895) 1 (55/4,006) 2 (29/1,344) 4 (22/545) <0.001
Right ICA/right CCA bifurcation 2 (102/5,895) 2 (64/4,006) 2 (26/1,344) 2 (12/545) 0.48
Pre-procedure target lesion stenosis, % 85  8 (5,895) 85  8 (4,006) 85  9 (1,344) 84  9 (545) 0.005
Target lesion length, mm 18  9 (5,845) 19  8 (3,969) 18  10 (1,338) 19  12 (538) <0.001
Target site calciﬁcation
None 23 (1,339/5,881) 20 (788/3,996) 30 (402/1,342) 27 (149/543) <0.001
Mild 54 (3,155/5,881) 56 (2,245/3,996) 49 (657/1,342) 47 (253/543) <0.001
Heavy 24 (1,387/5,881) 24 (963/3,996) 21 (283/1,342) 26 (141/543) 0.03
Thrombus present at target site 4 (215/5,887) 3 (115/4,000) 5 (71/1,342) 5 (29/545) <0.001
Aortic arch type
I 43 (2,528/5,848) 41 (1,640/3,977) 51 (674/1,334) 40 (214/537) <0.001
II 44 (2,550/5,848) 44 (1,761/3,977) 41 (542/1,334) 46 (247/537) 0.03
III 13 (770/5,848) 15 (576/3,977) 9 (118/1,334) 14 (76/537) <0.001
Target lesion echogenicity
Completely soft 20 (1,114/5,507) 19 (696/3,709) 23 (304/1,322) 24 (114/476) <0.001
Completely calciﬁed 7 (403/5,507) 7 (250/3,709) 8 (100/1,322) 11 (53/476) 0.002
Mixed 73 (3,990/5,507) 75 (2,763/3,709) 69 (918/1,322) 65 (309/476) <0.001
Aortic arch characteristic
Diseased 52 (3,030/5,843) 55 (2,187/3,975) 41 (549/1,332) 55 (294/536) <0.001
Final residual stenosis, % 10  10 (5,887) 11  10 (4,001) 7  10 (1,341) 9  11 (545) <0.001
Values are mean  SD (n) or % (n/N).
Abbreviations as in Table 1.
TABLE 3 Experience
Characterist
Operator
Baseline operator CAS
Operator CAS volume i
study (sequence)
Time from ﬁrst CAS to
subsequent CAS pro
Time between each CA
days
Institution volume
Values are n.
CAS ¼ carotid artery ste
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1310routine testing with electrocardiogram or cardiac
enzyme measurements after the procedure. For the
purpose of endpoint analyses, patients who had an
additional CAS procedure $31 days after the previous
CAS procedure were consented again and counted as
a new patient. For patients who were treated with
bilateral CAS procedures within an interval of #30
days, endpoints were assessed with respect to
each procedure, and baseline demographic andData for the Analysis Population
ic Minimum Maximum Median
25th
Percentile
75th
Percentile
volume 1 1,000 100 37 155
n the 1 195 10 4 26
each
cedure, days
0 1,827 379 106 707
S procedure, 0 1,450 16 3 50
1 260 22 8 51
nting.comorbidity data from the ﬁrst procedure were used
in the analysis.
STATISTICAL ANALYSIS. The analysis population
(N ¼ 5,841) was described overall and by clinician
medical specialty, consisting of cardiology (n ¼
3,969), surgery (n ¼ 1,331), and radiology/neurology
(n ¼ 541). Baseline demographics, comorbidities,
lesion characteristics, and procedural data for the
entire cohort and by clinician medical specialty are
presented using descriptive summary statistics.
Among the 5 operator variables, 2 (baseline operator
volume and operator medical specialty) were deﬁned
at the operator level. The remaining 3 operator vari-
ables (time from ﬁrst CAS to each subsequent CAS
procedure, time between each CAS procedure, and
operator CAS volume in the analysis) were deﬁned at
the patient level because the values of these variables
vary for each patient. Similarly, institution volume
was also a patient-level variable based on the
deﬁnition.
The impact of operator and institution variables on
EPD dwell time and 30-day DSMI were assessed using
multivariable regression analyses while adjusting for
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FIGURE 1 Mean EPD Dwell Time According to Operator and Institution Experience Variables
Of the 3 medical specialties, cardiology had the lowest mean embolic protection device (EPD) dwell time (A). In general, the mean EPD dwell
time was lower with increasing operator (B to E) and institution experience (F) with carotid artery stenting (CAS). The comparison groups for
B to F were determined arbitrarily based on raw data and presumed clinical relevance.
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TABLE 4
(Log Tran
Baseline o
Cardiologi
Radiology
Surgery vs
Operator C
Time from
proced
Time betw
Institution
Bivalirudin
Coronary
Target site
Previous c
Unstable a
History of
Target site
Hyperchol
Awaiting c
Recent MI
Target les
Post-proc
Pre-proce
MI ¼ myoca
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1312important patient baseline variables. Of the 6 oper-
ator and institution variables, baseline operator CAS
volume was available in 5,240 (of 5,841) patients, and
the analysis therefore was limited to this population.
The steps involved in the regression modeling pro-
cess were as follows. First, patient baseline variables
were examined with respect to distribution and
amount of missing values. The EPD dwell time was
not normally distributed; therefore, the log trans-
formation of the EPD dwell time was used in the
analysis. There was a small percentage of missing
values in patient baseline variables (<2% in 24
variables, <4% in 7 variables, and <9% in 3 variables).
To improve statistical efﬁciency and potentially avoid
bias, missing patient baseline values were imputed
using the fully conditional speciﬁcation method
based on predictive mean matching (12). This was
veriﬁed by sensitivity analyses using the Markov
chain Monte Carlo method, which assumes multi-
variate normality (13). Furthermore, multiple (n ¼ 10)
imputed datasets were created to reﬂect the un-
certainties on the imputed values (12). Second,
important baseline patient, lesion, and procedural
variables (Tables 1 and 2) were identiﬁed using step-
wise regression analyses (linear regression for
dwell time and logistic regression for 30-day
DSMI). In addition, bootstrap bagging methods withHierarchical Linear Regression Analysis on EPD Dwell Time
sformed) (n ¼ 5,240)
Variable Coefﬁcient (SE) p Value
perator CAS volume, in hundreds –0.0061 (0.0090) 0.50
st (reference) 0.0000 —
/neurology vs. cardiology 0.2203 (0.0517) <0.001
. cardiology 0.2115 (0.0372) <0.001
AS volume in the study, in hundreds –0.0148 (0.0511) 0.77
ﬁrst CAS to each subsequent CAS
ure for operator, months
–0.0028 (0.0008) <0.001
een each CAS procedure, months 0.0038 (0.0020) 0.06
volume, in hundreds –0.0112 (0.0342) 0.74
, yes vs. no –0.0360 (0.0247) 0.15
artery disease, yes vs. no –0.0145 (0.0129) 0.26
calciﬁcation, heavy vs. mild or none 0.0893 (0.0143) <0.001
arotid endarterectomy, yes vs. no 0.0145 (0.0157) 0.36
ngina, yes vs. no 0.0303 (0.0285) 0.29
congestive heart failure, yes vs. no –0.0055 (0.0143) 0.70
calciﬁcation, heavy or mild vs. none –0.0115 (0.0153) 0.45
esterolemia, yes vs. no 0.0419 (0.0173) 0.02
ardiac surgery within 30 days 0.0256 (0.0376) 0.50
within 30 days –0.0354 (0.0540) 0.51
ion length, mm 0.0063 (0.0007) <0.001
edure ﬁnal residual stenosis, % 0.0036 (0.0006) <0.001
dure target lesion stenosis, % 0.0055 (0.0007) <0.001
rdial infarction.an inclusion frequency of 60% were used (14,15).
Third, to incorporate the hierarchical nature of the
data, statistical methods that address the within-
operator clustering were employed. A linear mixed
model was used for EPD dwell time, and a hierar-
chical logistic regression was used for 30-day DSMI.
Both models included 6 operator and institution
variables and adjusted for important patient baseline
variables. The hierarchical regression analyses were
performed on each of the 10 imputed datasets, and
the respective results for EPD dwell time and DSMI
were combined to generate valid inferences using
the method by Rubin (13). All statistical analyses
were performed using SAS software (version 9.2,
SAS Institute, Cary, North Carolina) and R software
(R Foundation, Vienna, Austria).
RESULTS
EXPERIENCE AND EPD DWELL TIME. Among the 3
clinician medical specialties, cardiologists had the
lowest mean EPD dwell time (p < 0.001) (Figure 1A). A
pattern of lower EPD dwell time was also noted with
increasing levels of operator and institutional expe-
rience (Figures 1B to 1F). In hierarchical multivariable
linear regression analysis, operator experience, as
measured by a prolonged time interval from ﬁrst CAS
to each subsequent CAS for the operator (p < 0.001)
and cardiology specialty (vs. surgery or radiology/
neurology, p < 0.001) were independent predictors
of lower EPD dwell time (Table 4, Figures 2A and 2B).
Moreover, a shorter time interval between each CAS
procedure for the operator showed a trend toward
lower EPD dwell time (p ¼ 0.06). The presence of
heavy calciﬁcation at the target lesion site, target
lesion length, and pre- and post-procedure lesion
stenosis were other signiﬁcant predictors of pro-
longed EPD dwell time (Table 4).
EXPERIENCE AND DSMI. At 30-day post-procedure
follow-up, DSMI and DS occurred in 4.1% and 3.6%,
respectively, in a mixed population of symptomatic
(14%) and asymptomatic (86%) patients with carotid
stenosis. Occurrence of any stroke, major stroke, and
fatal stroke was 3.2%, 0.8%, and 0%, respectively.
In unadjusted analysis, cardiologists and surgeons
had lower 30-day DSMI than did radiologists/neurol-
ogists (Figure 3A). For the other operator and insti-
tution variables, DSMI rates were similar across the
different experience levels (Figures 3B to 3F). In the
adjusted hierarchical multivariable logistic regression
analysis (Table 5), operator experience, as measured
by a prolonged time interval between each CAS pro-
cedure for the operator, was a signiﬁcant predictor of
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FIGURE 2 Relative Change in EPD Dwell Time According to Experience and Clinician Specialty in Adjusted Analyses
In adjusted analyses, the time from ﬁrst CAS to each subsequent CAS procedure for operator was found to be inversely related to EPD dwell time (technical performance)
as illustrated in A with 95% conﬁdence interval shown as dashed lines. In comparison to cardiology (reference group), surgery and radiology/neurology specialties had
relatively higher EPD dwell times for any given time from ﬁrst CAS to each subsequent CAS (B). Abbreviations as in Figure 1.
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1313DSMI (adjusted odds ratio: 1.05, 95% conﬁdence in-
terval: 1.02 to 1.09, p ¼ 0.005) (Figure 4A). However,
there was no association between medical specialty
and DSMI (Figure 4B). Similar associations were also
noted for the DS outcome (Table 5). Patient-related
factors that were also signiﬁcant predictors of DSMI
included age, symptomatic carotid disease, history
of coronary artery disease, aortic arch disease, and
chronic kidney disease.
EPD DWELL TIME AND DSMI. The mean EPD dwell
time for the entire analysis population (N ¼ 5,841)
was 13.5  8.1 min. In unadjusted analysis, a reduced
EPD dwell time was associated with better DSMI rates
(Figure 5A). In a hierarchical multivariable logistic
regression analysis, after adjusting for baseline pa-
tient variables and operator experience variables,
prolonged EPD dwell time was associated with a
higher 30-day DSMI rate (adjusted odds ratio: 1.08;
95% conﬁdence interval: 1.01 to 1.17; p ¼ 0.03)
(Table 5, Figure 5B). The ﬁndings were again similar
when tested for the 30-day DS outcome (Table 5).
DISCUSSION
In this large, multicenter, prospective analysis to
evaluate outcomes with CAS using distal embolic
protection (Acculink/Accunet only), our results
demonstrate the following principal ﬁndings: 1)
operator experience characterized by time from ﬁrst
CAS, time to each subsequent CAS, and time interval
between CAS are closely associated with technical
performance as measured by EPD dwell time;2) longer time interval between CAS procedures is an
independent predictor of increased 30-day DSMI; and
3) decreasing EPD dwell time as a measure for tech-
nical proﬁciency and patient selection is associated
with improved clinical outcome (30-day DSMI). These
ﬁndings suggest the possible need to reconsider our
approach in deﬁning operator experience that has
thus far solely relied on baseline operator and insti-
tution CAS volumes.
With CAS, learning curves can be constructed in 2
broad domains: technical performance (EPD dwell
time) and clinical outcome (30-day DSMI). Whether
technical proﬁciency translates into better clinical
outcome has not been previously studied, although
earlier reports suggest an association between EPD
dwell time and periprocedural stroke risk (10,11). In
our adjusted analysis using the large amount of
CHOICE Acculink/Accunet data, we demonstrate that
a shorter EPD dwell time (technical proﬁciency) is
independently associated with reduced 30-day DSMI.
EPD dwell time is an important endpoint because it is
dependent on both operator- and patient-related
factors. The predictors of prolonged EPD dwell time
(heavy calciﬁcation at the target lesion site, history of
hypercholesterolemia, target lesion length, pre- and
post-procedure lesion stenosis) suggest the impor-
tance of proper patient selection. Furthermore, it
highlights technical proﬁciency in resolving compli-
cations during the procedure such as hemodynamic
disturbances or no-reﬂow due to distal embolization.
This analysis of the CHOICE post-market study is
well suited to provide deeper insights into the role of
operator experience on outcomes. Unlike previous
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FIGURE 3 30-day DSMI Rates According to Operator and Institution Experience Variables
Thirty-day death, stroke, and myocardial infarction (DSMI) rates are illustrated for the 3 clinician specialties (cardiology, surgery, and radiology/
neurology) in A. In unadjusted analysis, cardiologists and surgeons had lower 30-day DSMI than did radiologists/neurologists. No signiﬁcant
differences in 30-day DSMI rates were noted with increasing operator (B to E) or institution experience (F). The comparison groups for B to F
were determined arbitrarily based on raw data and presumed clinical relevance. CAS ¼ carotid artery stenting.
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TABLE 5 Hierarchical Logistic Regression Analysis on Composite Outcomes
(N ¼ 5,240)
Variable
Adjusted Odds Ratio
(95% CI) p Value
30-day death, stroke, and myocardial infarction
Baseline operator CAS volume, in hundreds 0.95 (0.86–1.04) 0.24
Cardiology (reference) 1.00 —
Radiology/neurology vs. cardiology 1.52 (0.92–2.51) 0.10
Surgery vs. cardiology 1.26 (0.84–1.89) 0.27
Operator CAS volume in the study
(sequence), in hundreds
1.39 (0.55–3.50) 0.48
Time from ﬁrst CAS to each subsequent
CAS procedure for operator, months
1.00 (0.98–1.01) 0.80
Time between each CAS procedure, months 1.05 (1.02–1.09) 0.005
Institution volume, in hundreds 1.01 (0.60–1.69) 0.98
Neurological symptom status, yes vs. no 1.71 (1.18–2.50) 0.005
Aortic arch diseased, yes vs. no 1.41 (1.04–1.91) 0.03
Coronary artery disease, yes vs. no 1.58 (1.12–2.22) 0.009
Chronic kidney disease, yes vs. no 1.46 (1.06–2.02) 0.02
Age, yrs 1.04 (1.02–1.06) <0.001
EPD dwell time, in 5-min increments 1.08 (1.01–1.17) 0.03
30-day death and stroke
Baseline operator CAS volume, in hundreds 0.92 (0.83–1.02) 0.11
Cardiology (reference) 1.00 –
Radiology/neurology vs. cardiology 1.18 (0.69–2.03) 0.54
Surgery vs. cardiology 1.12 (0.74–1.72) 0.59
Operator CAS volume in the study
(sequence), in hundreds
1.53 (0.59–3.97) 0.38
Time from ﬁrst CAS to each subsequent
CAS procedure for operator, months
1.00 (0.98–1.01) 0.74
Time between each CAS procedure, months 1.06 (1.02–1.10) 0.005
Institution volume, in hundreds 1.01 (0.58–1.75) 0.97
Neurologic symptom status, yes vs. no 1.89 (1.28–2.81) 0.002
Aortic arch diseased, yes vs. no 1.39 (1.00–1.92) 0.05
Thrombus, yes vs. no 1.85 (1.00–3.43) 0.05
Sex, female vs. male 1.42 (1.05–1.92) 0.02
Chronic kidney disease, yes vs. no 1.48 (1.05–2.10) 0.03
Age, yrs 1.05 (1.03–1.06) <0.001
EPD dwell time, in 5-min increments 1.09 (1.01–1.17) 0.03
CAS ¼ carotid artery stenting; EPD ¼ embolic protection device.
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1315studies such as CAPTURE and CAPTURE 2 (Carotid
RX Acculink/Accunet Post-Approval/Market Trials
to Uncover Unanticipated or Rare Events), CHOICE
enrolled patients at more institutions across the
United States (1,10). Operators had a wide range of
experience with CAS at baseline as measured by self-
reported operator volume and also represented a
variety of medical specialties. The hospital settings
were diverse and included community, private, and
teaching centers across the United States. Further-
more, stroke outcomes were adjudicated according
to a standardized deﬁnition. These features com-
bined with the statistical power provided by the
large sample size (>5,000) are extremely important
to address the effect of operator experience on
outcomes.
Based on available evidence, the association be-
tween operator experience and CAS outcomes follows
the pattern previously described for coronary angio-
plasty—the inverse “volume-outcome relationship”
(16,17). In CAPTURE 2 (n ¼ 5,297), Gray et al. (2) found
an inverse relationship between CAS operator volume
and 30-day DS. A similar relationship was noted with
hospital CAS volume. The ﬁndings were consistent
despite stratiﬁcation by 2 medical specialties, inter-
ventional cardiology and vascular surgery. However,
82% of the operators and 66% of the institutions
observed no events; therefore, their conclusions were
based on the few operators and institutions with
events. Moreover, the study by Gray et al. (2) was
limited to the asymptomatic nonoctogenarian patient
population. In another large CAS study using Medi-
care beneﬁciaries $65 years (n ¼ 24,701), Nallamothu
et al. (3) found an inverse relationship between
annual operator volume and 30-day mortality.
Despite the large sample size, the study was limited
by inclusion of CAS without EPD use, lack of data on
stroke or MI, and the absence of lesion or procedural
characteristics in the adjusted analyses.
In the present analysis, we attempted to improve
on the available evidence to date by introducing
2 time-related experience variables that were not
evaluated previously but could potentially affect
outcome. Time from ﬁrst CAS to each subsequent
CAS procedure for the operator is important for 2
reasons. First, operators are constantly improving
their skills with every vascular intervention they
perform even outside of carotids. A longer time from
ﬁrst enrollment would enable us to incorporate this
collateral experience. Second, it may facilitate ac-
counting for technological advancements that could
potentially affect operator outcomes. The other time-
related variable, namely the time between each CAS
procedure, is especially meaningful in the context oflow- or medium-volume operators or during the
operator’s early learning curve. Contrary to other
reports, our multivariable analysis failed to show a
signiﬁcant association between CAS volumes (oper-
ator or institution) and 30-day DSMI. This is possible
because operators and institutions with higher CAS
volumes also tend to treat more complex patients
such as those with symptoms and octogenarians.
Also, some operators may not have enrolled all the
patients on whom they performed CAS during the
study period. The time between each CAS procedure
for the operator was found to be a signiﬁcant pre-
dictor of DSMI, implying the need to quantify oper-
ator CAS volume over shorter intervals (procedures
per week or month) rather than per year or as total
numbers. Given the strong association of EPD dwell
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FIGURE 4 Adjusted Odds Ratios for 30-Day DSMI According to Experience and Clinician Specialty
The time between each CAS procedure for the operator is signiﬁcantly associated with 30-day DSMI (clinical outcome). The curve for adjusted odds of 30-day DSMI in
relation to increasing time interval between each CAS is demonstrated in A with 95% conﬁdence interval shown as dashed lines. (B) There are no signiﬁcant differences
in adjusted odds ratios for 30-day DSMI among the 3 clinician specialties for any given time interval between each CAS procedure. Abbreviations as in Figures 1 and 3.
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1316time with DSMI and of interval between CAS pro-
cedures and EPD dwell time, it may be possible to
establish a common goal that would reﬂect more
dynamic best practices for CAS operators that reﬂect
ongoing expertise in addition to expertise and
training at baseline alone.
STUDY LIMITATIONS. First, CHOICE is essentially
a descriptive study designed to investigate post-
marketing 30-day DSMI outcomes and is neitherociation Between EPD Dwell Time and 30-Day DSMI
hip exists between EPD dwell time (technical performance) and 30-day DSMI
D dwell time. A regression line with 95% conﬁdence limits (dashed lines) is
ted odds ratio for every 5-min increase in EPD dwell time. Despite adjustmen
ased odds of 30-day DSMI. Abbreviations as in Figures 1 and 3.randomized nor controlled to study varying levels
of operator expertise. However, all events were pro-
spectively adjudicated. Second, the operator volumes,
institution volumes, and time between each CAS pro-
cedurewere not inclusive of CAS procedures outside of
the study, which likely resulted in underestimation of
true experience. Although causal inferences cannot be
drawn, the overall ﬁndings are useful in improving our
understanding of time-dependent measures of expe-
rience. Third, EPD dwell time may also be inﬂuenced(clinical outcome) using raw data that was divided into 20 groups of
shown. (B) Hierarchical multivariable logistic regression analysis was
t for signiﬁcant confounders, an increase in EPD dwell time was
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1317by arch anatomy and technical difﬁculty with crossing
lesions. Nevertheless, given the association with 30-
day DSMI, careful patient selection based on anatomy
and lesion characteristics is paramount regardless of
operator experience. Because we did not study prox-
imal EPD, our ﬁndings cannot be extrapolated to this
population. Lastly, data on medication use, particu-
larly statins, were not available; this may have
confounded our results.
CONCLUSIONS
In this large analysis from a multicenter, prospective
study on the use of CAS with embolic protection,
operator experience, represented by time-relatedvariables, was closely associated with technical per-
formance and 30-day DSMI. The time interval be-
tween CAS procedures and the time from ﬁrst CAS to
subsequent CAS are important measures of operator
experience. Technical performance based on EPD
dwell time is a signiﬁcant predictor for 30-day DSMI.
As with any hypothesis-generating research, future
prospective studies will be needed to validate our
ﬁndings.
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